References
- Chapman B. Some Effects of the Rice-Fruit Diet in Patients with Essential Hypertension. Hypertension, E. T. Bell. University of Minnesota, Minneapolis 1951; 504–516, A Symposium
- Freis E. Comparative effects of Ticrynafen and Hydrochlorothiazide in the Treatment of Hypertension (Veterans Administration Cooperative Study Group on Antihypertensive Agents). N. Engl J Med. 1979; 301: 293–297
- Fujita T., Henry W. L., Bartter F. C., Lake C. R., Delea C. S. Factors Influencing Blood Pressure in Salt-Sensitive Patients with Hypertension. Am. J Med. 1980; 69: 334–344
- Hollenberg N. K., Merrill J. P. Intrarenal Perfusion in the young “Essential” Hypertensive: A Subpopulation Resistant to Sodium Restriction. Trans. Assoc Am Physicians, Lxxxiii: 93–101
- Williams G. H., Rose L. I., Dluhy R. G., McCaughn D., Jagger P. I., Hickler R. B., Lauler D. P. Abnormal Responsiveness of the Renin-Aldosterone System to Acute Stimulation in Patients with Essential Hypertension. Ann. Intern Med. 1970; 72: 317–326
- Hollenberg N K, Borucki L J, Adams D F. The renal vasculature in early essential hypertension: Evidence for a pathogenetic role. Medicine. 1978; 57: 167–178
- Williams G. H., Tuck M. L., Sullivan J. M., Dluhy R. G., Hollenberg N. K. Parallel Adrenal and Renal Abnormalities in the Young Patient with Essential Hypertension. Am. J Med. 1982; 72: 907–914
- Hollenberg N. K., Chenitz W. R., Adams D. F., Williams G. H. Reciprocal Influence of Salt Intake on Adrenal Glomerulosa and Renal Vascular Responses to Angiotensin II in Normal Man. J. Clin Invest. 1974; 54: 34–42
- Shoback D. M., Williams G. H., Moore T. J., Dluhy R. G., Podolsky S., Hollenberg N. K. Defect in the Sodium-Modulated Tissue Responsiveness to Angiotensin II in Essential Hypertension. J. Clin Invest. 1983; 72: 2115–2124
- Williams G. H., Hollenberg N. K. Are Non-Modulating Essential Hypertensives a Distinct Subgroup? Implication for therapy. Am. J Med. 1985; 79(3C)3–9
- Hollenberg N. K., Williams G. H. Abnormal Renal Sodium Handling in Essential Hypertension: Relation to Failure of Renal and Adrenal Modulation of Responses to Angiotensin II. Am. J Med. 7/85, In Press
- Redgrave J. E., Rabinowe S. L., Hollenberg N. K., Williams G. H. Correction of Abnormal Renal Blood Flow Response to Angiotensin II by Converting-Enzyme Inhibition in Essential Hypertensives. J. Clin Invest. 1985; 75: 1285–1290
- Rystedt L. L., Williams G. H., Hollenberg N. K. The Renal and Endocrine Response to Saline Infusion in Essential. Hypertension Hypertension 1986; 8: 217–222
- Laragh J. H. Vascoonstriction-Volime Analysis in Treatment of Hypertension. Hypertension: Mechanisms, Diagnosis and Management, J. O. Davis, J. H. Laragh, A. Selwyn. H.P. Publishing Co., New York, New York 1977; 69–74
- Laragh J. H., Case D. B., Atlas S. A., Sealey J. E. Captopril Compared with Other Antirenin System Agents in Hypertensive Patients: Its Triphasic Effects on Blood Pressure and its Use to Identify and Treat the Renin Factor. Hypertension 1980; 2: 586–593
- de Wardener H. E., MacGregor G. A. The Relation of a Circulating Sodium Transport Inhibitor to Essential Hypertension. Kidney in Hypertension. Martinus Nijhoff Publishing, Boston 1984; 1–14